December 01, 2006
Invitation to Tender: Centre for Health Technology Evaluation, Decision Support Unit (DSU)
Location: UK
Closing date: 1 December 2006
Details of our work programmes and examples of the guidance can be found on the NICE website.
The Institute is tendering for suppliers who can provide the current support offered to the Technology Appraisal Programme known as the Decision Support Unit (DSU). The primary role of the DSU is to provide rapid responses to technical issues raised by the NICE Appraisal Committee. The committee appraises the evidence on the use of the technology and produces national guidance for the NHS in England and Wales. The DSU will advise the technical team and associated academic groups and provide specific, high quality, clinical and cost effectiveness analyses to support the Appraisal Committee Decision making. The Institute is therefore inviting expressions of interest from organisations wishing to undertake the DSU work on behalf of NICE.
Please register your expression of interest by email titled DSU re-tender to barney.wilkinson@nice.org.uk by 5.00pm Friday 1st December 2006.
Tender packs will be dispatched to interested individuals/organisations by Friday 8th December 2006.
The National Institute for Health and Clinical Excellence (NICE) is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health.
The Institute is committed to the values of equality and diversity and welcomes applications from all sections of the community. We also promote flexible working.
December 01, 2006: Invitation to Tender
May 19, 2006
Health Economics Analysis for Physical Activity Programme Guidance (Expressions of Interest for an Invitation to Tender): National Institute for Health and Clinical Excellence (NICE)
Location: UK
Closing date: 19 May 2006 (for tender, but should express interest before)
CONTRACT: 16 months
BUDGET: £45K (exclusive of VAT)
NICE wishes to commission cost effectiveness analysis for programme guidance for the Highways Agency, Local Authorities, primary care, pharmacists, health visitors and community nurses, schools, workplaces, the leisure and fitness industry and sports clubs to meet the Chief Medical Officer’s physical activity recommendations.
Background: On 1 April 2005 the NICE took on the functions of the HDA to form the National Institute for Health and Clinical Excellence (NICE), with a Centre for Public Health Excellence (CPHE). NICE is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health.
The physical activity topics were referred to NICE (the Institute) by the Department of Health as part of the 11th wave of work for the development of public health programme guidance aimed at promoting physical activity.
The primary aim of this guidance is to recommend environmental interventions that will increase physical activity levels in the general population, particularly by:
- incorporating physical activity into every day life
- increasing recreational activity
- increasing active travel
The guidance will provide recommendations for good practice, based on the best available evidence of effectiveness, including cost effectiveness. It is aimed at professionals with public health as part of their remit working within the NHS, local authorities and the wider public, private, voluntary and community sectors.
Related pieces of work are reviews of the effectiveness of environmental interventions that will increase physical activity levels in the general population. These involve critically reviewing, grading and summarising the evidence. Factors that influence effectiveness will be identified, such as the nature of the interventions, the socio-demographic characteristics of the population under study, the settings within which the interventions are delivered and the “profession” of the practitioners providing the interventions.
Health Economics Research Aims and Objectives: A key aspect of NICE guidance is the consideration of cost effectiveness. Typically health economics input into guidance involves critically reviewing and summarising the most up-to-date economic research on aspects of care of specific relevance to the guidelines, and considering the cost-effectiveness of the guidance that is put forward as recommendations for health policy and practice. It is usual practice for there to be dedicated health economic input in guidance development.
The role of the health economist in guidance development is fourfold. He or she:
- helps to identify the public health/prevention issues or questions for economic analysis, through:
- through agreement with CPHE and the effectiveness rapid review contractors
- reviews economic literature, through:
- the preparation of the health economic evidence for presentation to the members of the Physical Activity Programme Development Group (PDG) at each meeting
- carries out or commissions cost-effectiveness analyses, through:
- the development and use of appropriate economic model(s) and
- provides assistance with the writing of the guidance in areas of cost effectiveness, through:
- attendance at the Physical Activity PDG meetings (eight)
- advice to the Physical Activity PDG on cost effectiveness matters
The NICE technical manual provides detailed information on standard health economic input into the development of guidance.
Expressions of interest with full contact details should be emailed to Dr Bhash Naidoo (bhash.naidoo@nice.org.uk) and the invitation to tender will be emailed by return from Tuesday 4th April 2006.
The closing date for the Tender itself will be 16:00 on Friday 19th May 2006.
Dr Bhash Naidoo
Technical Advisor
National Institute for Health and Clinical Excellence (NICE)
MidCity Place
71 High Holborn
London
WC1V 6NA
Telephone: 020 7400 0656
Fax: 020 7067 5801
Main switchboard : 020 7067 5800
Website: http://www.nice.org.uk/
May 19, 2006: Invitation to Tender
January 05, 2006
Health Economics Input: NPSA
Location: UK
Closing date: 5 January 2006
The NPSA is a Special Health Authority responsible for improving patient safety in health care organisations providing NHS-funded care in England and Wales. It works with health bodies to develop, implement and evaluate the effectiveness of patient safety solutions. The Department of Epidemiology and Research is building an evidence base in patient safety through a database of incidents and other sources.
We are inviting proposals for input from academic departments or other health economists to work collaboratively with the NPSA to further the patient safety agenda. Expertise in patient safety, health services evaluation and/or modelling would be preferred. Input may be on a part time or consultancy basis, with an annual budget of around 25-35k for two years in the first instance, funded by the NPSA, starting early in 2006.
Further details of the input required and how to apply are given in a tender specification document on our website.
For an informal discussion, please contact Tanya Huehns, Head of R&D at: Tanya.huehns@npsa.nhs.uk or Richard Thomson, Director of Epidemiology and Research at Richard.thomson@npsa.nhs.uk.
January 05, 2006: Invitation to Tender
August 30, 2005
Expressions of Interest for an Invitation to Tender, Health Economics Analysis of Physical Activity Interventions: National Institute for Health and Clinical Excellence (NICE)
Contract: 8 months (+ ~1 week during validation)
NICE wishes to commission cost effectiveness analysis for the assessment of four commonly used methods to increase physical activity: brief interventions in primary care, pedometers, exercise referral schemes and community based exercise programmes for walking and cycling.
Background: On 1 April 2005 the NICE took on the functions of the HDA to form the National Institute for Health and Clinical Excellence (NICE), with a Centre for Public Health Excellence (CPHE). NICE is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health.
Four physical activity topics were referred to NICE (the Institute) by the Department of Health as part of the 11th wave of work for the development of public health intervention guidance. These will produce recommendations on types of activity provided by local health organisations to help to promote or maintain a healthy lifestyle or reduce the risk of developing disease or conditions (for example, giving patients advice - at home, in GP practices or in clinics - to encourage them to be more physically active . This guidance will provide recommendations for good practice on three of these that are based on the best available evidence of effectiveness, including cost effectiveness. The fourth (brief advice in primary care) is covered by guidance published by NICE based on work carried out in 2004 - 5 by the former Health Development Agency.
A related piece of work, that is tendered separately, is a review of the effectiveness of these four commonly used methods to increase physical activity. This involves critically reviewing, grading and summarising the evidence. Factors that influence effectiveness will be identified, such as the nature of the brief interventions, the socio-demographic characteristics of the population under study, the settings within which the interventions are delivered and the “profession” of the practitioners providing the interventions.
Health Economics Research Aims and Objectives: A key aspect of NICE guidance is the consideration of cost effectiveness. Typically health economics input into clinical guidelines involves critically reviewing and summarising the most up-to-date economic research on aspects of care of specific relevance to the guidelines, and considering the cost-effectiveness of the guidance that is put forward as recommendations for health policy and practice. It is usual practice for there to be dedicated health economic input in guidance development.
The role of the health economist in guidance development is fourfold. He or she:
- helps to identify the public health/prevention issues or questions for economic analysis, through:
- through agreement with CPHE and the effectiveness rapid review contractors
- reviews economic literature, through:
- the preparation of the health economic evidence for presentation to the members of PHIAC at each meeting
- carries out or commissions cost-effectiveness analyses, through:
- the development and use of appropriate economic model(s) and
- provides assistance with the writing of the guidance in areas of cost effectiveness, through:
- attendance at the Public Health Interventions Advisory Committee (PHIAC) meetings (two)
- advice to PHIAC on cost effectiveness matters
The NICE technical manual provides detailed information on standard health economic input into the development of guidance. However, this methodology has to date only been used for clinical topics.
Expressions of interest with full contact details should be emailed to Dr Bhash Naidoo bhash.naidoo@nice.org.uk and the invitation to tender will be emailed by return.
Dr Bhash Naidoo
Senior Research Specialist
National Institute for Health and Clinical Excellence (NICE)
MidCity Place
71 High Holborn
London
WC1V 6NA
Telephone: 020 7400 0656
Fax: 020 7067 5801
Main switchboard : 020 7067 5800
Website: http://www.nice.org.uk/